Veritable, L.P. Incyte Corp Transaction History

Veritable, L.P.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 13, 2020	SELL	$85.07 - $109.69 $164,270 - $211,811	-1,931 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$74.18 - $108.93 $143,241 - $210,343	1,931 New	1,931 $201,000
Q1 2020 May 13, 2020	SELL	$63.18 - $85.97 $147,841 - $201,169	-2,340 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$73.04 - $95.72 $170,913 - $223,984	2,340 New	2,340 $204,000
Q1 2018 May 14, 2018	SELL	$83.06 - $100.98 $197,184 - $239,726	-2,374 Closed	0 $0
Q4 2017 Feb 13, 2018	BUY	$93.56 - $116.6 $17,963 - $22,387	192 Added 8.8%	2,374 $225,000
Q3 2017 Nov 14, 2017	BUY	$109.15 - $138.27 $238,165 - $301,705	2,182	2,182 $255,000

657

186M

714K

557K

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $16.5B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

Get notified when there are updates to the investment portfolio of Veritable, L.P., based on Form 13F filings with the SEC.

Stay updated on Veritable, L.P. with notifications on news.